The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Crumbs
At you say
“well if we ever hit a timeline and actually get an approved product “
The science has always been remarkable with so few pairs of hands and meagre budgets. The achievements have been outstanding . Some years have passed since CH joined who said we must get into clinical trials and gather data. We have Redmile monetary backing removing our biggest problem to moving forward at pace . If we can’t carry out the trials perhaps we should let Open Orphan help us out
Cathal Friel, CEO and Chairman at Open Orphan joined London South East last night at our April Investor Event. Watch his company announcements
Cathay Friel a very dynamic CEO with an incredible driving force
Perhaps every company should have one
From Bloomburg
“mRNA vaccines for Covid-19 have efficacy rates above 90%, much higher than the 60% rate for flu shots in a good year. But vaccine makers Moderna Inc. and Pfizer Inc., along with its partner BioNTech SE, aren’t taking any chances. Just in case, they’re already starting trials of booster shots aimed at B.1.351, the antibody-evading strain first spotted in South Africa.”
Can we start a PH1 study now, time is of the essence
Hi Roses,
“ Maxparker, nice to see you over on this board. You do know what field this company is in don’t you?”
Only posted here, After being invested for over 7years I’m fully aware of Scancell
Just wondering if our CEO’s pay plan is incentive driven and should we suggest some options to encourage time scales to be accurate. We all know this is difficult but H1 and H2 seems a little broad brush.
CEPI 100 day vaccines must scare the life out of him. Just a thought
Let’s hope some company can develop this great idea and a block buster product
Great science poor execution will lose the race. Looking forward to the half year update
The suspense will be difficult to contain
LL - news flow was promised Q1 2021
Now H1
The press reported progress in weeks (several weeks ago) and now you think a few months is OK.
Scancell didn’t say “no no they got the timing wrong” just look back at the SKY video clip. I would like to know what they are doing. Not an unreasonable request. I don’t want a RNS . Just a little communication
Katnick,
We know all this
“”If you want a vaccine to work Fast ....... High Avidity
If you want a broader response ........... High Avidity
If you want a strong memory T cell generated ....... High Avidity””
We just need to get into clinical trials soon
H1 will end in June2021. Come on Cliff you must have sorted the timetable out by now
Wild
“Hovering over the isa top up button today, but held off ... maybe tomorrow!? “
Don’t get too excited wait till next week you should be able to buy in the teens
Don’t think Cliff I to bothered money in the bank full salary hoppy days
Take care ....
Wild
“Universal Covid vaccines are the only solution to open the world back up ... ?”
Great pity Scancell don’t understand speed is of the essence. Update would be useful pre RNS No rush down 4% today
Take care all...
“University of Cape Town (UCT) researchers are expected to start a phase one clinical trial of the Covid-19 vaccine candidate, hAd5 T-cell, later this month “
It’s nice to see a South Africa second generation vaccine getting into a phase one trial
Take care all